Your fact-checks will appear here
Female given name
Peer‑reviewed randomized trials and large prevention studies show that multidomain lifestyle interventions can improve or slow cognitive decline in people who are at risk for dementia and in some smal...
Venture capital is often absent where commercial returns are unclear, and the reporting shows that in dementia research those gaps most frequently align with social-science, prevention/implementation ...
The available evidence does not show independently replicated, peer-reviewed clinical trial results demonstrating that a product named *Neurocept* improves clinical outcomes in Alzheimer's disease pat...
By 2023, a convergence of large observational cohorts, global reviews and early randomized studies strengthened the case that lifestyle matters for Alzheimer’s risk: combined healthy behaviors — regul...
There is no mention of a product or drug named “Neuro Defender” in the supplied reporting, and therefore no documented clinical trials of Neuro Defender for cognitive decline or Alzheimer’s disease ca...
MemoBlast’s label reportedly hides exact ingredient amounts, so independent reviewers conclude its doses are not transparently reported and cannot be compared to doses used in human randomized control...
To verify death or major health claims about a public figure, go to primary, authoritative sources first: official statements from family or representatives, government death records or registries, ho...